Clicky

Atea Pharmaceuticals, Inc.(AVIR)

Description: Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.


Keywords:

Home Page: ateapharma.com

AVIR Technical Analysis

125 Summer Street
Boston, MA 02110
United States
Phone: 857 284 8891


Officers

Name Title
Dr. Jean-Pierre Sommadossi Ph.D. Founder, Chairman, CEO & Pres
Ms. Andrea J. Corcoran J.D. CFO, Exec. VP of Legal & Sec.
Mr. John F. Vavricka Chief Commercial Officer
Dr. Janet M. J. Hammond M.D., Ph.D. Chief Devel. Officer
Dr. Maria Arantxa Horga M.D. Chief Medical Officer
Mr. Wayne Foster CPA, CPA Exec. VP of Fin. & Chief Accounting Officer
Ms. Jonae R. Barnes Sr. VP of Investor Relations & Corp. Communications
Mr. Ariyapadi N. Krishnaraj VP of Marketing
Mr. Adel Moussa Ph.D. Exec. VP of Chemistry
Mr. Xiao-Jian Zhou Ph.D. Exec. VP of Early Stage Devel.

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 12.3158
Price-to-Book MRQ: 0.5513
Price-to-Sales TTM: 1.9026
IPO Date: 2020-10-30
Fiscal Year End: December
Full Time Employees: 68
Back to stocks